Your browser doesn't support javascript.
loading
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century.
Stertman, Linda; Palm, Anna-Karin E; Zarnegar, Behdad; Carow, Berit; Lunderius Andersson, Carolina; Magnusson, Sofia E; Carnrot, Cecilia; Shinde, Vivek; Smith, Gale; Glenn, Gregory; Fries, Louis; Lövgren Bengtsson, Karin.
Affiliation
  • Stertman L; Department Product Development, Novavax AB, Uppsala, Sweden.
  • Palm AE; Department Product Development, Novavax AB, Uppsala, Sweden.
  • Zarnegar B; Department Product Development, Novavax AB, Uppsala, Sweden.
  • Carow B; Department Product Development, Novavax AB, Uppsala, Sweden.
  • Lunderius Andersson C; Department Product Development, Novavax AB, Uppsala, Sweden.
  • Magnusson SE; Department Alliance and Project Management, Novavax AB, Uppsala, Sweden.
  • Carnrot C; Department Alliance and Project Management, Novavax AB, Uppsala, Sweden.
  • Shinde V; Department Research and Development, Novavax, Inc, Gaithersburg, MD, USA.
  • Smith G; Department Research and Development, Novavax, Inc, Gaithersburg, MD, USA.
  • Glenn G; Department Research and Development, Novavax, Inc, Gaithersburg, MD, USA.
  • Fries L; Department Research and Development, Novavax, Inc, Gaithersburg, MD, USA.
  • Lövgren Bengtsson K; Department Product Development, Novavax AB, Uppsala, Sweden.
Hum Vaccin Immunother ; 19(1): 2189885, 2023 12 31.
Article in En | MEDLINE | ID: mdl-37113023

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saponins / Vaccines / COVID-19 Limits: Humans Language: En Journal: Hum Vaccin Immunother Year: 2023 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saponins / Vaccines / COVID-19 Limits: Humans Language: En Journal: Hum Vaccin Immunother Year: 2023 Type: Article Affiliation country: Sweden